GEMPHIRE THERAPEUTICS INC - COM (GEMP)

CUSIP: 36870A108

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
3,413,768
Share change
+256,581
Total reported value
$32,409,000
Price per share
$9.50
Number of holders
25
Value change
+$1,558,013
Number of buys
15
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 36870A108?
CUSIP 36870A108 identifies GEMP - GEMPHIRE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GEMPHIRE THERAPEUTICS INC - COM (GEMP) as of Q3 2017

As of 30 Sep 2017, GEMPHIRE THERAPEUTICS INC - COM (GEMP) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,413,768 shares. The largest 10 holders included Cormorant Asset Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Exchange Capital Management, Inc., NORTHPOINTE CAPITAL LLC, BAMCO INC /NY/, Cambridge Investment Research Advisors, Inc., VANGUARD GROUP INC, COMERICA BANK, RAYMOND JAMES & ASSOCIATES, and Telemetry Investments, L.L.C.. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.